8
Oct
2024

Galenica S.A

Exhibitor at CPHI Milan 2024 stand 16C57, Finished Dosage Formulations
About Us

Galenica is one of the largest Greek pharmaceutical companies which promotes research and serves health with consistency and scientific responsibility, by developing high-quality and innovative pharmaceutical products. Founded in 1974 by the pharmacists Denis Varelas and Basile Tamvacas, it became very soon one of the most dynamic companies in the sector with impressive rates of growth and development. It is the first Greek company that focused on the acquisition of know how and marketing of ethical products, through ...

  • GR
  • 2016
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
Distributor/Import Export
Licensee
Manufacturer/Innovator
Other
Pharmaceutical company
Primary activities
Contract Manufacturer
Out-licensing specialist
Pharmaceutical Company (innovator finished products)
Contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 16C57, Finished Dosage Formulations

Products Featured at CPHI Milan 2024

  • DEXARIS

    Product DEXARIS

    Active ingredients:   Dexamethasone isonicotinate/ Oxymetazoline hydrochloride

    Therapeutic indications:
    Allergic rhinitis (hay fever, vasomotor rhinitis), acute rhinitis and rhinopharyngitis, sinusitis and nasal polyps.

  • DERMISET

    Product DERMISET

    Active ingredients: 
    Triamcinolone Acetonide+Salicylic Acid 

    Indications: 
    Eczema and corticosteroid-responsive skin diseases characterized by hyperkeratoses and/or squamous cell formation.
    Psoriasis, excluding large psoriasis plaques
    Lichenification of the skin.
    Neur...
  • DIMENHYDRINATE SUBLINGUAL

    Product DIMENHYDRINATE SUBLINGUAL

    Active ingredient: Dimenhydrinate 50mg/tab
    Therapeutic target: Antinausea - motion sickness. 


    Contact us for more information.